(PRO Views are exclusive to PRO subscribers, giving them insight on the news of the day direct from a real investing pro. See the full discussion above.) New York Stock Exchange insider Jay Wood pointed to rising momentum in Pfizer and two other beaten-down stocks that he believes pro traders should watch ahead of their upcoming quarterly results. As markets sit in the lull period between the last earnings season and the next, the chief market strategist at Freedom Capital Markets called out Pfizer as a name could continue to gain as investors look to the final quarter of the year. "Pfizer, talk about a turnaround ... health care, pharma stocks starting to turn around because of that news last week. Let's see if that momentum can continue," Woods said. "When you're looking at levels in Pfi

See Full Page